|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Pre-tax book loss | ||||
| Depreciation | ||||
| Loss on asset disposal | ||||
| Impairment of assets | ||||
| Stock-based compensation | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable and accrued liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from issuance of Series B Convertible Preferred Stock | ||||
| Proceeds from issuance of Common Stock | ||||
| Repayment of investor advances | ||||
| Repayment of related party notes | ||||
| Net cash provided by financing activities | ||||
| Effect of foreign exchange rate on cash | ||||
| Net increase (decrease) in cash | ||||
| Cash at beginning of period | ||||
| Cash at end of period | ||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||
| Issuance of common stock for the acquisition of mining concessions | ||||
| Conversion of Series B Convertible Preferred to common stock | ||||
Loading...
